Information:
Fel:
ID
29360
Beskrivning
Study part: Investigator/ Site Change (Unscheduled). A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.
Nyckelord
Versioner (1)
- 2018-03-20 2018-03-20 -
Rättsinnehavare
Roche
Uppladdad den
20 mars 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Investigator/ Site Change (Unscheduled) Ranibizumab Macular Edema Diabetes Mellitus FVF4168g
Investigator/ Site Change (Unscheduled)
- StudyEvent: ODM
Similar models
Investigator/ Site Change (Unscheduled)
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Subject Number
Item
Subject Number:
text
C2348585 (UMLS CUI [1])
Subject Initials
Item
Subject Initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
C2986440 (UMLS CUI [1,2])
Date of report
Item
Report Date:
text
C1302584 (UMLS CUI [1])
Investigator Number
Item
Investigator Number:
text
C2826689 (UMLS CUI [1])
Site Number
Item
Site Number:
text
C2825164 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
Date of change
Item
Effective Date of Change:
date
C0011008 (UMLS CUI [1,1])
C0443172 (UMLS CUI [1,2])
C0443172 (UMLS CUI [1,2])